These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Alam MJ; Alam O; Khan SA; Naim MJ; Islamuddin M; Deora GS Drug Des Devel Ther; 2016; 10():3529-3543. PubMed ID: 27826185 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Gedawy EM; Kassab AE; El Kerdawy AM Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Abdel-Sayed MA; Bayomi SM; El-Sherbeny MA; Abdel-Aziz NI; ElTahir KE; Shehatou GS; Abdel-Aziz AA Bioorg Med Chem; 2016 May; 24(9):2032-42. PubMed ID: 27025563 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme. El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504 [TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530 [TBL] [Abstract][Full Text] [Related]
18. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones. Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]